Ratio of Urinary Potassium to Urinary Sodium and the Potassium and Edema Status in Nephrotic Syndrome

Internal Medicine

Volumn 50, Issue 6, 2011, Pages 551-555

  Matsumoto, Hiroshi ^a   Miyaoka, Yoshitaka ^a   Okada, Tomonari ^a   Nagaoka, Yume ^a   Wada, Toshikazu ^a   Gondo, Asako ^a   Esaki, Shinga ^a   Hayashi, Ami ^a   Nakao, Toshiyuki ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Aldosterone; Diuretics; Fractional excretion of sodium; Minimal change nephrotic syndrome; Remission

Indexed keywords

BIOLOGICAL MARKER; POTASSIUM; SODIUM;

ADULT; ARTICLE; COMPARATIVE STUDY; EDEMA; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; RETROSPECTIVE STUDY; URINE;

ADULT; BIOLOGICAL MARKERS; EDEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PATIENT ADMISSION; POTASSIUM; RETROSPECTIVE STUDIES; SODIUM;

EID: 80755124988     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4537     Document Type: Article

References (14)

1. Bradley SE, Tyson CJ. The ‘nephrotic syndrome’. N Engl J Med 238: 223 and 260–266, 1948.
2. Brown EA, Markandu ND, Sagnella GA, Jones BE, McGregor GA. Sodium retention in the nephrotic syndrome is due to an in-trarenal defect evidence from steroid-induced remission. Nephron 39: 1237–1239, 1985.
3. Schrier RW, Fassett RG. A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney Int 53: 1111–1117, 1998.
4. Tabel Y, Mungan I, Karakurt C, Kocak G, Gungor S. Is edema in minimal change disease of children really hypovolemic? Int Urol Nephrol 40: 757–761, 2008.
5. Kapur G, Valentini RP, Imam AA, Mattoo TK. Treatment of severe edema in children with nephrotic syndrome with diuretics alone-A prospective study. Clin J Am Soc Nephrol 4: 907–913, 2009.
6. Vande Walle JG, Donckerwolcke RA, Van Isselt JW, Derkx FHM, Joles JA, Koomans HA. Volume regulation in children with early relapse of minimal-change nephrotic syndrome with or without hypovolemic symptoms. Lancet 346: 148–152, 1995.
7. Vande Walle JG, Donckerwolcke RA, Koomans HA. Pathophysi-ology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol 10: 323–331, 1999.
8. Hene RJ, Koomans HA, Boer P, Roos JC, Dorhout Mees EJ. Relation between plasma aldosterone concentration and renal handling of sodium and potassium, in patients with chorinic renal failure. Nephron 37: 94–99, 1984.
9. Usberti M, Federico S, Meccariello S, et al. Role of plasma vaso-pressin in the impairment of water excretion in nephrotic syndrome. Kidney Int 25: 422–429, 1984.
10. Joles A, Rabelink TJ, Braam B, Koomans HA. Plasma volume regulation: Defences against edema formation (with special emphasis on hypoproteinaemia). Am J Nephrol 13: 399–412, 1993.
11. Koomans HA, Geers AB, Dorhout Mees EJ, Kortlandt W. Lowered tissue-fluid oncotic pressure protects the blood volumes in the nephrotic syndrome. Nephron 42: 317–322, 1986.
12. Remuzzi G, Imberti L, Rossini M, et al. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. J Clin Invest 75: 94–101, 1985.
13. Shibasaki T, Matsuda H, Gomi H, Usui M, Ishimoto F, Sakai O. Mizoribine reduces urinary protein excretion in rats given puromy-cin aminonucleoside. Am J Nephrol 16: 167–172, 1996.
14. Matsumoto H, Nakao T. Elevated urinary excretion of thromboxane B2 in adults with minimal-change nephrotic syndrome. Clin Nephrol 53: 75–76, 2000.